Researchers develop new way to genetically engineer T cells for treating leukemia relapse – News-Medical.net
News-Medical.net |
Researchers develop new way to genetically engineer T cells for treating leukemia relapse
News-Medical.net This immunotherapy represents a different method of genetic engineering than the CAR T-cell therapies that were recently approved by the U.S. Food and Drug Administration. Relapse occurs in about one-third of patients with acute leukemia who undergo … |
